About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood ...

In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...

From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...

A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...

The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites ...

The gene p53 acts as a tumor suppressor and often is called the ‘guardian of the genome.’ This gene is central to maintaining genomic stability, which prevents mutations from accumulating and leading ...

Precision and timing of gene expression is essential for normal biological functions and, when disrupted, can lead to many ...

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

From hair regrowth to safe pregnancy chemotherapy and new targeted therapies, these top five breast cancer stories of 2025 ...

Doctors are seeing colon cancer in people in their 20s and 30s. New research suggests it starts in infancy.